These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38425695)

  • 1. Positron emission tomography and its role in the assessment of vulnerable plaques in comparison to other imaging modalities.
    Proaño-Bernal L; Gilabert-García A; Sharma-Sharma S; Mora-Barrera CM; Singer-De-la-Garza J; Beristain-de-la-Rosa PY; Basile-Alvarez MR; Guerra EC; Bermudez-Gonzalez JL; Luna-Alcala S; Espinola-Zavaleta N; Alexanderson-Rosas E
    Front Med (Lausanne); 2023; 10():1293848. PubMed ID: 38425695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques.
    Adamson PD; Vesey AT; Joshi NV; Newby DE; Dweck MR
    Cardiovasc Diagn Ther; 2015 Apr; 5(2):150-5. PubMed ID: 25984456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.
    Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging.
    Douhi A; Al-Enezi MS; Berrahmoune N; Khalil A; Fulop T; Nguyen M; Turcotte E; Croteau É; Bentourkia M
    Phys Eng Sci Med; 2023 Mar; 46(1):295-302. PubMed ID: 36715851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
    Joshi NV; Vesey AT; Williams MC; Shah AS; Calvert PA; Craighead FH; Yeoh SE; Wallace W; Salter D; Fletcher AM; van Beek EJ; Flapan AD; Uren NG; Behan MW; Cruden NL; Mills NL; Fox KA; Rudd JH; Dweck MR; Newby DE
    Lancet; 2014 Feb; 383(9918):705-13. PubMed ID: 24224999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal
    Zhuang X; Feng Y; Li J; Zhao F; Zhang Y; Chen Y
    Cardiovasc Diagn Ther; 2021 Feb; 11(1):39-49. PubMed ID: 33708476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.
    Wurster TH; Landmesser U; Abdelwahed YS; Skurk C; Morguet A; Leistner DM; Fröhlich G; Haghikia A; Engel LC; Schuster A; Noutsias M; Schulze D; Hamm B; Furth C; Brenner W; Botnar RM; Bigalke B; Makowski MR
    Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1391-1398. PubMed ID: 35015852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
    Dweck MR; Chow MW; Joshi NV; Williams MC; Jones C; Fletcher AM; Richardson H; White A; McKillop G; van Beek EJ; Boon NA; Rudd JH; Newby DE
    J Am Coll Cardiol; 2012 Apr; 59(17):1539-48. PubMed ID: 22516444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pet tracers for vulnerable plaque imaging.
    Giannakou S; Angelidis G; Tsougos I; Valotassiou V; Kappas K; Georgoulias P
    Ann Nucl Med; 2020 May; 34(5):305-313. PubMed ID: 32193790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2010 Mar; 12(2):179-84. PubMed ID: 20425174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.